282 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
events in T2DM + ASCVD ... events in T2DM + ASCVD ... or ASCVD risk; ... MACE, in T2DM + ASCVD ... or ASCVD risk.
ABCDE of Primary ASCVD Prevention: Lifestyle Changes and Team-Based Care - Checklist
A – Antiplatelet Therapy
B –
ABCDE of Primary ASCVD ... #PrimaryCare #ASCVD ... Checklist #ABCs #ACCAHA
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
- Established ASCVD ... or CKD - Without ... established ASCVD ... or CKD #Diabetes
ABCDE of Primary Prevention: Lifestyle Changes and Team-Based Care - Checklist
A – Antiplatelet Therapy
B – Blood
#PrimaryCare #ASCVD ... Checklist #ABCs #ACCAHA
Definitions of AKI, CKD, AKD
Acute Kidney Injury (AKI):
 • Increase in SCr by 2 50% within
Definitions of AKI, CKD ... , AKD Acute Kidney ... Kidney Disease (CKD ... /CKD • No structural ... damage #AKI #CKD
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
metformin in T2D and CKD ... alpha-glucosidase inhibitor: ASCVD ... cardiovascular disease: CKD ... , #KDIGO2020 #CKD ... Management in CKD
ACC/AHA 2018 Cholesterol Guideline Algorithm for Secondary Prevention

#Cholesterol #Guidelines #Algorithm #ACCAHA #2018 #Cardiology #Statins #PCSK9
Guidelines #Algorithm #ACCAHA
Mesenteric Ischemia - Differential Diagnostic Schema
Chronic: ASCVD, Venous, Vasculitides 5% (PAN, [E]GPA, IgA, MPA)
Acute
 - Venous
Schema Chronic: ASCVD ... hypo-/akinesis), ASCVD ... failure, Dissection, ASCVD
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... Staging #Stages #ACCAHA
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Dissection • CKD ... , DM, ESRD, PKD